
## **Trustees’ Annual Report for the period** 

## **From  1 April 2022  Period start date   To   31 March 2023         Period end date** 

## **Charity name: Oxford Academic Health Partners** 

## **Charity registration number:  1174725** 

## **Objectives and Activities** 

|**Objectives and Activities**|||
|---|---|---|
||SORP<br>reference||
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|To advance health by research, clinical care,<br>education and training to provide solutions so<br>that clinical research breakthroughs lead to<br>direct clinical benefits.|
|Summary of the main activities<br>in relation to those purposes<br>for the public benefit, in<br>particular, the activities,<br>projects or services identified in<br>the accounts.|Para 1.17 and<br>1.19|OAHP will support its purpose through providing<br>grant funding, and hosting function that fulfil its<br>objectives and the provision of services.|
|Statement confirming whether<br>the trustees have had regard to<br>the guidance issued by the<br>Charity Commission on public<br>benefit|Para 1.18|The Trustees confirm that they have not varied<br>the constitution of the Charity and therefore as<br>assessed by the Charity commission at<br>formation, comply with PB1 of the Guidance.<br>We also confirm that in preparing this report we<br>have operated OAHP with due regard to<br>Guidance PB2 ensuring that all steps taken to<br>achieve public benefit have been for a charitable<br>purpose.  This reporting period, activity has been<br>to secure modest funds and develop an<br>approach to grant funding as detailed below, but<br>we confirm that we have given due regard to<br>Guidance PB3 in this matter.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

||SORP<br>reference||
|---|---|---|
|Policy on grant making|Para 1.38|Grants and awards from OAHP will be provided<br>and governed through grant conditions with the<br>recipient accepting those conditions for<br>management and reporting on activities<br>supported through OAHP funds.<br>Grant making is an accepted form of providing<br>funds to support research and education,<br>especiallyin the health and life sciences sector.|



1 



|||For this reason, the Trustees have chosen this as<br>the route for distributing funds to achieve the<br>aims of OAHP across its Partner organisations.|
|---|---|---|
|Policy on social investment<br>including program related<br>investment|Para 1.38|OAHP is not intending to use Social Investment<br>as a route to achieve its goals.|
|Contribution made by<br>volunteers|Para 1.38|OAHP is not using volunteers to undertake<br>charitable activities.|
|Other|||



## **Achievements and Performance** 

||SORP<br>reference||
|---|---|---|
|Summary of the<br>main<br>achievements of<br>the charity,<br>identifying the<br>difference the<br>charity’s work<br>has made to the<br>circumstances of<br>its beneficiaries<br>and any wider<br>benefits to<br>society as a<br>whole.|Para 1.20|The key activity for the year ending 31 March 2023 was the<br>implementation of the Research Development Award<br>introduced to support the development of research capability,<br>capacity, and clinical academic careers with a focus on the<br>Partners’ nurses, midwives, Allied Health Professionals and<br>Pharmacists and with an emphasis on research projects and<br>courses, potential legacy, collaboration, and partnership<br>working and further spread across OAHP.<br>Research evidence drives improvements in the quality of care<br>provided to patients and service users and can yield solutions<br>to some of the day-to-day challenges of delivering high-quality<br>health and care services.<br>Research-active healthcare organisations tend to see better<br>patient outcomes, report higher levels of patient experience,<br>and have better staff recruitment and retention compared<br>with those who are less research active.  Across England, the<br>culture and support to include allied health professionals and<br>other frontline workers in clinical research programmes is<br>lacking.<br>The Research Development Award Scheme takes steps to<br>address this, supporting the development of a research culture<br>that is inclusive of all professionals and patients.<br>The scheme is part of OAHP’s ongoing strategy of championing<br>research literacy across the clinical and allied health<br>disciplines,to helpbuild and maintain the foundations for|



2 



robust, interdisciplinary health and care research. The initial sum available from the OAHP was £50,000 and this pot was increased to £72,5000 with contributions from NIHR Oxford Biomedical Research Centre (BRC) and NIHR Oxford Health Biomedical Research Centre making the total amount significant.  The generosity of the two BRCs is acknowledged as is the contribution (in kind) from the NIHR Oxford and Thames Valley Applied Research Collaboration. Applications were invited on 22 May 2022 and the process closed on 22 July 2022.  All 50 applications were acknowledged and individuals kept updated on the process to date. The judging panel, made up senior healthcare professionals, researchers and academics from across the Partners, met on 15 August 2022 and used several criteria in the selection of 26 Awards covering 19 professional groups from four of the OAHP partners.  The Awards were ratified by the Board of the Oxford Academic Health Partners at its meeting on 26 August 2022. An update on the Awards is available here The nature of the awards ranged from funding for a MSc in Leadership in Health and Social Care at the University of Derby for OUH Hand Therapist Zoe Miles, funding support for a shortterm (three month) collaborative research project between Oxford Health NHS Foundation Trust and the Centre for Suicide Research University of Oxford that focused on suicide and selfharm in nurses.  The work was completed and published in the Journal of Advanced Nursing in August 2023 as “Suicidal Thoughts and Behaviours amongst student nurses and midwives”.  Other awards included funds to support Amanda Colston,  Senior Research Nurse and Team Lead in the Mental Health Clinical Research facility, Oxford Health NHS FT and the NIHR Oxford Health Biomedical Research Centre continue her studies at Cardiff University and is undertaking a systematic review of the aftercare needed for patients who receive genetic results as part of a clinical trial. The interest from a very wide range of individuals from all OAHP Partners was strong and the spread across the organisations was appropriate. The Judging Panel highlighted the overall strong nature of the applications. The Award is regarded as both the means of improving research capacity and capability across the Partners in support of individuals’ learning and development of clinical academic careers and a highly successful means of raising the profile of the Charity, O AHP and its Partners. Reports are being received on the impact of the Awards made particularly in relation to the development of research capability and capacity as a means of personal and professional development and developments in the care of patients and their families. 

3 



The Award was highlighted in one of the case studies submitted to NIHR in July 2023 in support of the OAHP Annual Report for 2022/2023. An extract is given below: “This knowledge and insight gained by completing my first year of doctorate of nursing, not only transformed my understanding of nursing as a discipline, as an art form and science, but also transformed my clinical practice which directly affects my decisions relating to patient care and the quality of care.” Advanced Nurse Practitioner. “The focus of my PhD is the investigation of the experiences of patients living with musculoskeletal impairments following critical illness, and to inform the development of a complex intervention.” Critical Care Physiotherapist ICU Work in the development of clinical academic careers for nonmedical healthcare professionals continues across individual Partners with the strong support of the Oxford Academic Health Partners Board and team. All payments made by the Charity relate to the Awards apart from the regular bank charges made by HSBC. Four Awards from the previous financial year were also made during the year completing the 21/22 Charity Awards. One Awardee from 2021/22, a Consultant in Palliative Care, said “Thank you for the substantial grant of £1500 toward attending the conference and understanding palliative care practice in Quebec province. The conference was of excellent quality ……. I have worked as a specialist in palliative medicine for 25 years and in the field for 30 years and it is rare to learn from almost every speaker. This conference provided that opportunity.” 

## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Achievements against<br>objectives set|Para 1.41|**n/a**|
|---|---|---|
|Performance of fundraising<br>activities against objectives set|Para 1.41|**n/a**|
|Investment performance<br>against objectives|Para 1.41|**n/a**|
|Other||**n/a **|



4 



## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s financial<br>position at the end of the<br>period|Para 1.21|The year end position is strong with funds<br>available to complete the payment of funds to<br>Awardees.|
|Statement explaining the policy<br>for holding reserves stating why<br>theyare held|Para 1.22|**n/a**|
|Amount of reserves held|Para 1.22|**n/a **|
|Reasons for holding zero<br>reserves|Para 1.22|**n/a**|
|Details of fund materially in<br>deficit|Para 1.24|**n/a**|
|Explanation of any<br>uncertainties about the charity<br>continuingas agoingconcern|Para 1.23|**n/a**|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|The charity’s principal sources<br>of funds (including any<br>fundraising)|Para 1.47|Contributions from the Partners and other<br>associated bodies including NIHR Oxford<br>Biomedical Research Centre, NIHR Oxford Health<br>Biomedical Research Centre and NIHR Applied<br>Research Collaborative Oxford and Thames<br>Valley.|
|---|---|---|
|Investment policy and<br>objectives including any social<br>investmentpolicyadopted|Para 1.46|**n/a**|
|A description of the principal<br>risks facingthe charity|Para 1.46|**n/a**|
|Other||**n/a**|



## **Structure, Governance and Management** 

|Description of charity’s trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed,royal charter)|Para 1.25|Constitution|
|How is the charity constituted?<br>(e.g. unincorporated<br>association,CIO)|Para 1.25|CIO|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of any<br>person or body entitled to<br>appoint one or more trustees|Para 1.25|The five Trustees are fixed as they are corporate<br>Trustee and there are no plans to expand the<br>group.  The Trustee do however appoint<br>representatives to help in the day to day running<br>of the CIO in accordance with its constitution.<br>These were selected and agreed by the Board of<br>Trustees at a board meeting in 2017.  In effect<br>the Board of the Oxford Academic Health<br>Partners act in this way.|



5 



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Policies and procedures<br>adopted for the induction and<br>training of trustees|Para 1.51|**n/a**|
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the charity<br>works|Para 1.51|**n/a**|
|Relationship with any related<br>parties|Para 1.51|**n/a**|
|Other||**n/a **|



## **Reference and Administrative details** 

|Charityname|Oxford Academic Health Partners|
|---|---|
|Other name the charityuses||
|Registered charitynumber|1174724|
|Charity’s principal address|c/o Joint Research Office, OUH Cowley<br>Floor 2 Unipart House,<br>Garsington Road,<br>Oxford OX4 2PG|



**Names of the charity trustees who manage the charity** 

|1<br>1<br>2<br>3|**Trustee name**|**Office (if any)**|**Dates acted if not for**<br>**whole year**|**Name of person (or body)**<br>**entitled to appoint trustee (if**<br>**any)**|
|---|---|---|---|---|
||Dr Bruno Holthof|CEO, Oxford University<br>Hospitals, Headley<br>Way, Headington,<br>Oxford, OX3 9DU|To 30 June 2022|Oxford University Hospitals NHS<br>FT|
||Professor Meghana<br>Pandit|CEO, Oxford University<br>Hospitals, Headley<br>Way, Headington,<br>Oxford, OX3 9DU|From 1 July 2022 (interim)<br>and 1 February 2023<br>(permanent)|Oxford University Hospitals NHS<br>FT|
||Dr Nick Broughton|CEO, Oxford Health<br>NHS FT Warneford<br>Hospital<br>Warneford Lane<br>Headington<br>Oxford OX3 7JX||Oxford Health NHS FT|
||Professor Gavin<br>Screaton|Head of Medical<br>Sciences Division,<br>Level 3, The John<br>Radcliffe Hospital,<br>Headley Way,<br>Headington Oxford<br>OX3 9DU||University of Oxford|



6 



|4<br>5<br>6|Professor Linda King|Pro Vice-Chancellor,<br>Research and Global<br>Partnerships<br>Oxford Brookes<br>University, Headington<br>Rd, Oxford OX3 0BP||Oxford Brookes University|
|---|---|---|---|---|
||Professor Sir John<br>Bell|Chair of OAHP Board<br>and Regius Professor<br>of Medicine,<br>University of Oxford,<br>Old Road, Oxford|||
||Professor Gary Ford|CEO, Health<br>Innovation Oxford and<br>Thames Valley||Health Innovation Oxford and<br>Thames Valley|



Corporate trustees – names of the directors at the date the report was approved 

|**Director name**|||
|---|---|---|
|Professor Meghana Pandit|**OUH NHS FT**||
|Dr Karl Marlowe|**OH NHS FT**|**Previously Dr Nick Broughton**<br>**to 30 June 2023**|
|Professor Gavin Screaton|**University of Oxford**||
|Professor Linda King|**Oxford Brookes University**||
|Professor Gary Ford|**Health Innovation Oxford and**<br>**Thames Valley**|**Formerly Oxford Academic**<br>**Health Science Network**|
|**OAHP**|||
|Professor John Bell|Chairman OAHP Board||
|Megan Turmezei|SecretaryOAHP Board||



Name of trustees holding title to property belonging to the charity **NONE** 

|**Trustee name**|**Dates acted if not for whole**<br>**year**||
|---|---|---|
||||
||||



## **Funds held as custodian trustees on behalf of others** 

|Description of the assets held in<br>this capacity|n/a|
|---|---|
|Name and objects of the charity<br>on whose behalf the assets are<br>held and how this falls within<br>the custodian charity’s objects|n/a|
|Details of arrangements for<br>safe custody and segregation of<br>such assets from the charity’s<br>own assets|n/a|



## **Additional information (optional)** 

**Names and addresses of advisers (Optional information)** 

7 



**Type of Name Address adviser** 

**Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

## **Other optional information** 

## **Declarations** 

## **The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 


**----- Start of picture text -----**<br>
Signature(s)<br>Full name(s)  Professor Sir John Bell  Megan  Turmezei<br>    Position (e.g. Secretary,  Chairman, OAHP Board  Secretary, OAHP Board<br>Chair, etc)<br>Date 25 January 2024  25 January 2024<br>**----- End of picture text -----**<br>


8 



||**Oxford Academic Health Partners**|**Oxford Academic Health Partners**|**Oxford Academic Health Partners**|**1174725**|**1174725**|**1174725**|**CC16a**|
|---|---|---|---|---|---|---|---|
||**For the period**<br>**from**|01/04/2022<br>Period start date|**To**||31/03/2023<br>Period end date|||
|||||||||
|**Section A Receipts and payments**||||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**7,500**<br>**98**<br>**15,000**<br>**-**<br>**-**<br> **22,598**<br>**-**<br>**-**<br> **-**<br>**22,598**<br>**56,830**<br>**60**<br>**-**<br> **56,890**<br>**-**<br>**-**<br> **-**<br>**56,890**<br>**-               34,292**<br>**-**<br>**55,763**<br>**21,471**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**Total funds**<br>**to the nearest £**<br>**7,500**<br>**98**<br>**15,000**<br>**-**<br>**-**<br>**22,598**<br>**-**<br>**-**<br>**-**<br>**22,598**<br>**56,830**<br>**60**<br>**-**<br>**56,890**<br>**-**<br>**-**<br>**-**<br>**56,890**<br>**-               34,292**||**Last year**<br>**to the nearest £**|
|Contribution from Oxford Health BRC|**7,500**||||||**40,000**|
|refund from Universityof Oxford|**98**||||||**-**|
|Contribution from Oxford BRC|**15,000**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**22,598**||||||**40,000**|
|||||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||||
||**-**|||||||
||**-**||||||**-**|
|**_Sub total_**|**-**||||||**-**|
|**_Total receipts_**<br>**A3 Payments**||||||||
||||||||**40,000**|
|||||||||
|<br>CharityAwards|**56,830**||||||**-**|
|Bank charges|**60**||||||**-**|
||**-**||||||**-**|
|**_Sub total_ **|**56,890**||||||**-**|
|||||||||
|**A4 Asset and investment**<br>**purchases (see table)**||||||||
|**,**|**-**|||||||
||**-**|||||||
|**_Sub total_ **|**-**||||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||||
||||||||**-**|
|||||||||
||**-               34,292**|**-**|**-**||**-               34,292**||**40,000**|
||**-**|**-**|**-**||**-**||**-**|
||**55,763**|**-**|**-**||**55,763**||**-**|
||**21,471**|**-**|**-**||**21,471**||**40,000**|



CC1174725 R1 accounts (SS) 

25/01/2024 

1 



|**Section B Statement of assets and liabilities at**|**Section B Statement of assets and liabilities at**|**the end of the period**|**the end of the period**||
|---|---|---|---|---|
|**Categories**<br>**B5 Liabilities**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>Professor Sir John Bell<br>Megan Turmezei<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>balance at year end<br>**B1 Cash funds**<br>**Details**<br>**Details**<br>**Signature**|**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>**Details**<br>**Details**<br>balance at year end<br>**Details**<br>**Details**|**Unrestricted**<br>**funds**<br>**to nearest £**<br>**21,471**<br>**-**<br>**21,471**<br>OK<br>**Unrestricted**<br>**funds**<br>**to nearest £**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**|**Restricted**<br>**funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>OK<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**Cost (optional)**<br>**Cost (optional)**<br>**-**<br>**-**<br>**Amount due**<br>**(optional)**<br>**-**|**Endowment**<br>**funds**<br>**to nearest £**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||OK|
|||||**Endowment**<br>**funds**<br>**to nearest £**<br>**Current value**<br>**(optional)**<br>**Current value**<br>**(optional)**|
|||||**-**|
|||||**-**|
|||||**When due**<br>**(optional)**|
||||||
||||||
||**Signature**|**Print Name**||**Date of**<br>**approval**|
|||John Bell<br>Megan<br>Turmezei||25-Jan-24<br>25-Jan-24|



CC1174725 R2 accounts (SS) 

25/01/2024 

2 

